03:37 PM EST - Stem Cell Therapeutics Corp. : reports its loss for the six-month period ended June 30, 2009 narrowed to $1.87 million or $0.01 per share from $2.89 million or $0.03 per share in the previous year. The company attributed the reduction in loss to decreases in research and development costs, general and administration expenses, management and consulting fees and deemed interest charges offset by a decrease in interest income earned during the period. The Company also announced that an aggregate of 960,000 stock options will be issued to SCT's officers and Board of Directors on Friday, August 28 based on the closing price of Thursday, August 27. Stem Cell Therapeutics Corp.
shares V.SSS are trading up $0.01 at $0.13.
